SCHEMBL2171949

SCHEMBL2171949

Fc1nc2ccccc2c(Br)c1F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.40
ALDH1A1 P00352 6/20 0.40
HPGD P15428 3/20 0.40
GLA P06280 3/20 0.40
SMN1; SMN2 Q16637 3/20 0.40
MAOA P21397 2/20 0.40
CASP1 P29466 2/20 0.40
CASP7 P55210 2/20 0.40
HSD17B10 Q99714 2/20 0.40
CHRM2 P08172 1/20 0.40
ADRA2A P08913 1/20 0.40
ADORA3 P0DMS8 1/20 0.40
CHRM1 P11229 1/20 0.40
NQO2 P16083 1/20 0.40
DRD1 P21728 1/20 0.40
ACHE P22303 1/20 0.40
SLC6A2 P23975 1/20 0.40
ADRA1A P35348 1/20 0.40
OPRM1 P35372 1/20 0.40
KCNH2 Q12809 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30528247 0.80 KDM4E (0.44) KDM4EALDH1A1HPGDGLASMN1; SMN2
SCHEMBL15058512 0.80 KDM4E (0.44) KDM4EALDH1A1HPGDGLASMN1; SMN2
SCHEMBL28360035 0.78 KDM4E (0.43) KDM4EALDH1A1HPGDGLASMN1; SMN2
SCHEMBL2512737 0.77 KDM4E (0.56) KDM4EALDH1A1HPGDGLASMN1; SMN2
SCHEMBL30918027 0.75 ACHE (0.61) KDM4EALDH1A1HPGDGLASMN1; SMN2
SCHEMBL538767 0.75 KDM4E (0.40) KDM4EALDH1A1HPGDGLASMN1; SMN2
SCHEMBL538014 0.75 MAOA (0.61) KDM4EALDH1A1HPGDGLASMN1; SMN2
SCHEMBL13943889 0.75 ALDH1A1 (0.49) KDM4EALDH1A1HPGDGLASMN1; SMN2
Bicarbonate SCHEMBL10810371 0.73 SMN1; SMN2 (0.42) KDM4EALDH1A1HPGDGLASMN1; SMN2
SCHEMBL7523835 0.73 GPR3 (0.54) KDM4EALDH1A1HPGDGLASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2346830-A1 GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE Merck Sharp & Dohme Corp. (US) 2011-07-27 EP disclosed
WO-2010030722-A1 GLUCAGON RECEPTOR ANTAGONIST COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND METHODS OF USE MERCK SHARP & DOHME CORP. (US) 2010-03-18 WO disclosed